|
The DOPPS is a prospective cohort study of hemodialysis practices based on the collection of observational longitudinal
data for a random sample of patients from a representative and random sample of units in 12 countries
(Australia, Belgium, Canada, France, Germany, Japan, Italy, New Zealand, Spain, Sweden, the United Kingdom, and the United States).
Data collection for the study has been on-going since 1996 and has yielded detailed data on more than 38,000 patients in over 900
dialysis facilities.
|
DOPPS investigations focus on determining which dialysis practices are associated with the best patient outcomes,
with the primary goal
of improving patient longevity, quality of life, and other outcomes. With over 75 peer-reviewed publications in
print or in press, the DOPPS continues to provide numerous important findings that are relevant for patients and practicing clinicians
alike. The DOPPS is supported by research grants from Amgen and Kirin Pharma, without restrictions on publications.
|
Robert M. Merion, M.D. will succeed Friedrich K. Port, M.D. M.S, as the third president of the Arbor Research Collaborative for Health, the organization’s Board of Directors is very pleased to announce.
More...
New research from the DOPPS will be presented during a clinical symposium at WCN 2009, the joint meeting
between ERA-EDTA and ISN. The symposium, to be chaired by Dr. Friedrich Port and Dr. Jorge Andia-Cannata,
will feature recent results from the DOPPS and Cosmos. Presentations will focus on clinical practice
indicators at the dialysis facility level and associated outcomes with consideration of patient mix. Emphasis
will be given to the international perspectives of DOPPS. Additionally, eight abstract presentations will be
given, on subjects including anemia management, mineral bone disease, and many others. Please see our
brochure for further details and a complete listing of DOPPS events occurring at WCN this
year.
The two-hour symposium is entitled “DOPPS: Recent International Evidence for Best Practices and Outcomes”,
and will provide new and unpublished findings from the DOPPS. Potential areas of focus include Nutritional,
Cardiovascular Practices, and modifiable practices followed by a panel discussion. The presentations will emphasize
DOPPS findings that are relevant to direct patient care, with the goal to improve patient care in hemodialysis units.
The symposium is entitled “Modifiable hemodialysis practices: latest trends and outcomes from the DOPPS". The session will be chaired by Dr. Bruce Robinson and features an international panel of speakers from DOPPS. The program, which is still under development, will take a critical look at the DOPPS study to present the study’s most recent clinical findings. The program will highlight modifiable practices in areas such as cardiovascular disease, anemia and MBD management. More information will be released as it becomes available.
|
|
The DOPPS has published more than 60 papers in peer-reviewed medical journals,
as well as numerous articles in textbooks and other forums.
See our Publications section for detail on the full range of DOPPS publications.
DOPPS Vascular Access Mortality Paper Published
Facility-based analyses diminish treatment-by-indication bias and suggest that less catheter and graft use improves patient survival.
More...
DOPPS Vitamin D Survival Advantage Paper Published
The association between vitamin D and mortality among DOPPS participants is assessed using standard regression
and marginal structural models with an expanded set of covariates, as well as by instrumental variable models to
account for potential bias due to unmeasured confounders. Based on route of vitamin D administration, no difference
in mortality is observed.
More...
DOPPS Practice-Related Risk Score (PRS) Paper Published
The PRS assesses modifiable hemodialysis practices that are linked to improved patient survival.
More...
|
|
DOPPS Reports
Each issue of the DOPPS report summarizes a selection of recent publications.
|
DOPPS Presentations of Published Research 2000-2008
|
|